Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 195097, 6 pages
http://dx.doi.org/10.1155/2014/195097
Clinical Study

Translational Research of Telecare for the Treatment of Hepatitis C

1Institute of Injury Prevention and Control, Taipei Medical University, Taipei 110, Taiwan
2College of Public Health and Nutrition, Taipei Medical University, Taipei 110, Taiwan
3International SOS, Taipei 104, Taiwan
4Ministry of Health and Welfare, Taipei 115, Taiwan
5Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan
6Department of Emergency, College of Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei 235, Taiwan

Received 18 March 2014; Accepted 13 May 2014; Published 10 June 2014

Academic Editor: Wei-Pin Chang

Copyright © 2014 Wan-Lin Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Y. Lai, “Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan,” Intervirology, vol. 49, no. 1-2, pp. 91–95, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. E. J. Heathcote, M. L. Shiffman, W. G. E. Cooksley et al., “Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis,” The New England Journal of Medicine, vol. 343, no. 23, pp. 1673–1680, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. D. Lee, M. L. Yu, P. N. Cheng et al., “Comparison of a 6-month course peginterferon α-2b plus ribavirin and interferon α-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan,” Journal of Viral Hepatitis, vol. 12, no. 3, pp. 283–291, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. W. Fried, M. L. Shiffman, K. Rajender Reddy et al., “Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection,” The New England Journal of Medicine, vol. 347, no. 13, pp. 975–982, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. S. H. Tsai, C. M. Tsang, H. R. Wu et al., “Transporting patient with suspected SARS,” Emerging Infectious Diseases, vol. 10, no. 7, pp. 1325–1326, 2004. View at Google Scholar · View at Scopus
  6. S. H. Tsai, W. L. Chen, C. M. Yang et al., “Emergency air medical services for patients with head injury,” Surgical Neurology, vol. 66, no. 2, pp. S32–S36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S.-H. Tsai, J. Kraus, H.-R. Wu et al., “The effectiveness of video-telemedicine for screening of patients requesting emergency air medical transport (EAMT),” Journal of Trauma: Injury, Infection and Critical Care, vol. 62, no. 2, pp. 504–511, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. W. Bates and A. A. Gawande, “Improving safety with information technology,” The New England Journal of Medicine, vol. 348, no. 25, pp. 2526–2534, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Osterberg and T. Blaschke, “Adherence to medication,” The New England Journal of Medicine, vol. 353, no. 5, pp. 487–497, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. W. C. Grant, R. R. Jhaveri, J. G. McHutchison, K. A. Schulman, and T. L. Kauf, “Trends in health care resource use for hepatitis C virus infection in the United States,” Hepatology, vol. 42, no. 6, pp. 1406–1413, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. D. B. Strader, T. Wright, D. L. Thomas, and L. B. Seeff, “Diagnosis, management, and treatment of hepatitis C,” Hepatology, vol. 39, no. 4, pp. 1147–1171, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. G. M. Lauer and B. D. Walker, “Hepatitis C virus infection,” The New England Journal of Medicine, vol. 345, no. 1, pp. 41–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Zeuzem, S. V. Feinman, J. Rasenack et al., “Peginterferon alfa-2a in patients with chronic hepatitis C,” The New England Journal of Medicine, vol. 343, no. 23, pp. 1666–1672, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. C. M. Lee, S. N. Lu, C. H. Hung et al., “Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, pp. 767–774, 2006. View at Google Scholar
  15. W.-L. Chuang, M.-L. Yu, C.-Y. Dai, and W.-Y. Chang, “Treatment of chronic hepatitis C in southern Taiwan,” Intervirology, vol. 49, no. 1-2, pp. 99–106, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Heinzelmann, N. E. Lugn, and J. C. Kvedar, “Telemedicine in the future,” Journal of Telemedicine and Telecare, vol. 11, no. 8, pp. 384–390, 2005. View at Google Scholar · View at Scopus
  17. K. Patel and J. G. McHutchison, “Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and duration,” Cleveland Clinic Journal of Medicine, vol. 71, no. 3, p. -S12, 2004. View at Google Scholar · View at Scopus
  18. S.-C. Kang, S.-J. Hwang, S.-H. Lee, F.-Y. Chang, and S.-D. Lee, “Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan,” World Journal of Gastroenterology, vol. 11, no. 47, pp. 7494–7498, 2005. View at Google Scholar · View at Scopus
  19. E. G. Poon, A. K. Jha, M. Christino et al., “Assessing the level of healthcare information technology adoption in the United States: a snapshot,” BMC Medical Informatics and Decision Making, vol. 6, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Ball and J. V. Douglas, “Redefining and improving patient safety,” Methods of Information in Medicine, vol. 41, no. 4, pp. 271–276, 2002. View at Google Scholar · View at Scopus
  21. P. Kouri, R. Karjalainen-Jurvelin, and J. Kinnunen, “Commitment of project participants to developing health care services based on the Internet technology,” International Journal of Medical Informatics, vol. 74, no. 11-12, pp. 1000–1011, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. L. Yu, C. Y. Dai, and S. C. Chen, “High versus standard doses interferon-alpha in the treatment of naive chronic hepatitis C patients in Taiwan: a 10-year cohort study,” BMC Infectious Diseases, vol. 12, no. 5, article 27, 2005. View at Google Scholar